ES2163195T3 - Derivados sustituidos de benzocicloheptapiridina utiles para inhibir la farnesil protein transferasa. - Google Patents

Derivados sustituidos de benzocicloheptapiridina utiles para inhibir la farnesil protein transferasa.

Info

Publication number
ES2163195T3
ES2163195T3 ES97941478T ES97941478T ES2163195T3 ES 2163195 T3 ES2163195 T3 ES 2163195T3 ES 97941478 T ES97941478 T ES 97941478T ES 97941478 T ES97941478 T ES 97941478T ES 2163195 T3 ES2163195 T3 ES 2163195T3
Authority
ES
Spain
Prior art keywords
transferasa
benzocicloheptapiridina
inhibit
useful
farnesil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97941478T
Other languages
English (en)
Inventor
Arthur G Taveras
F George Njoroge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2163195T3 publication Critical patent/ES2163195T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Confectionery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS COMPUESTOS DE FORMULA (1.0). DICHOS COMPUESTOS SE REPRESENTAN MEDIANTE LAS FORMULAS (1.4) O (1.5), EN LAS QUE R 1 , R 3 Y R 4 SE SELEC CIONAN CADA UNO INDEPENDIENTEMENTE A PARTIR DE LOS ELEMENTOS HALOGENOS. W REPRESENTA UN GRUPO SELECCIONADO A PARTIR DE (A), (B), (C) O (D). ASIMISMO, SE DESCRIBEN PROCEDIMIENTOS DE INHIBICION DE LA FARNESIL PROTEINA TRANSFERASA Y DEL CRECIMIENTO DE CELULAS ANORMALES, COMO CELULAS TUMORALES.
ES97941478T 1996-09-13 1997-09-11 Derivados sustituidos de benzocicloheptapiridina utiles para inhibir la farnesil protein transferasa. Expired - Lifetime ES2163195T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71192596A 1996-09-13 1996-09-13

Publications (1)

Publication Number Publication Date
ES2163195T3 true ES2163195T3 (es) 2002-01-16

Family

ID=24860067

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97941478T Expired - Lifetime ES2163195T3 (es) 1996-09-13 1997-09-11 Derivados sustituidos de benzocicloheptapiridina utiles para inhibir la farnesil protein transferasa.

Country Status (21)

Country Link
EP (1) EP0931079B1 (es)
JP (1) JP2001500508A (es)
KR (1) KR20000036103A (es)
CN (1) CN1122031C (es)
AT (1) ATE209201T1 (es)
AU (1) AU4337797A (es)
BR (1) BR9711477A (es)
CA (1) CA2264513C (es)
CZ (1) CZ87499A3 (es)
DE (1) DE69709774T2 (es)
ES (1) ES2163195T3 (es)
HK (1) HK1018443A1 (es)
HU (1) HUP9904056A3 (es)
ID (1) ID22156A (es)
IL (1) IL128929A0 (es)
NO (1) NO991229L (es)
NZ (1) NZ334437A (es)
PL (1) PL332253A1 (es)
SK (1) SK33599A3 (es)
TR (1) TR199901205T2 (es)
WO (1) WO1998011099A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358968B1 (en) 1997-06-17 2002-03-19 Schering Corporation N-substituted urea inhibitors of farnesyl-protein transferase
IL133389A0 (en) * 1997-06-17 2001-04-30 Schering Corp Novel n-substituted urea inhibitors of farnesyl-protein transferase
EP1049700B9 (en) 1998-01-21 2006-05-10 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
JP2002501052A (ja) 1998-01-21 2002-01-15 ミレニアム・ファーマシューティカルズ・インコーポレイテッド ケモカイン受容体アンタゴニストおよびその使用方法
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
NZ326035A (en) * 1995-12-22 2000-01-28 Schering Corp Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
EP0931079A1 (en) 1999-07-28
HUP9904056A2 (hu) 2000-04-28
DE69709774T2 (de) 2002-08-08
CA2264513A1 (en) 1998-03-19
HK1018443A1 (en) 1999-12-24
NO991229L (no) 1999-05-12
HUP9904056A3 (en) 2001-10-29
WO1998011099A1 (en) 1998-03-19
KR20000036103A (ko) 2000-06-26
AU4337797A (en) 1998-04-02
JP2001500508A (ja) 2001-01-16
CA2264513C (en) 2004-03-30
TR199901205T2 (xx) 1999-07-21
CN1236364A (zh) 1999-11-24
NO991229D0 (no) 1999-03-12
PL332253A1 (en) 1999-08-30
DE69709774D1 (de) 2002-02-21
IL128929A0 (en) 2000-02-17
ID22156A (id) 1999-09-09
ATE209201T1 (de) 2001-12-15
BR9711477A (pt) 1999-08-24
CZ87499A3 (cs) 1999-08-11
SK33599A3 (en) 2000-03-13
CN1122031C (zh) 2003-09-24
EP0931079B1 (en) 2001-11-21
NZ334437A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
FI931708A (fi) Herbicida substituerade aryl-haloalkylpyrazoler
ATE12042T1 (de) Aminosaeurederivate und ihre therapeutische verwendung.
BR9712831A (pt) Inibidores tricìclicos de farnesil proteìna transferase
AR001020A1 (es) Derivados de fenildicetona, procedimientos para prepararlos, las composiciones herbicidas que los contienen y el procedimiento para combatir elcrecimiento de las plantas indeseables con dichos derivados.
ES2163195T3 (es) Derivados sustituidos de benzocicloheptapiridina utiles para inhibir la farnesil protein transferasa.
ES529593A0 (es) Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona
EA200201083A1 (ru) Противоопухолевые производные эктейнасцидина
TR200101868T2 (tr) Sülfonamit hidroksamatlar.
DK0971922T3 (da) Tetrahydropyrido-forbindelser
BG106847A (en) Substituted piperazine derivatives as mtp inhibitors
ID21577A (id) Komposisi-komposisi yang berguna untuk tranferase protein farnesil
UY26265A1 (es) Compuestos calciolíticos
ATE277017T1 (de) 1,2-disubstituierte 1,4-dihydro-4-oxochinolin- verbindungen
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
SE9604582D0 (sv) Novel compounds
PT1054869E (pt) Derivados de 3,4-di-hidroquinolina como inibidores de sintases dommonoxido de azoto (nos)
ES527854A0 (es) Procedimiento de preparar compuestos tratamiento de la hipertension
DE69808922D1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
DK0915858T3 (da) Mellemprodukter til fremstilling af 2-imidazolin-5-oner
ES2178224T3 (es) Derivados de benzo (5,6)ciclohepta(1,2-b)piridina para la inhibicion de la farnesil proteina transferasa.
ES2052812T3 (es) Un procedimiento para la preparacion de derivados de pirrolizina.
ATE247106T1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl protein transferase inhibitoren
AR013306A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlos, las composiciones herbicidas que los contienen y el procedimiento de aplicacion dedichos compuestos.
AR006676A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlos, las composiciones herbicidas que los contienen y el procedimiento de aplicacion dedichos compuestos.
BR9712035A (pt) Compostos Úteis para inibi-Æo de transferase de prote¡na farnesila

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 931079

Country of ref document: ES